343 related articles for article (PubMed ID: 34950107)
1. Analysis of N6-Methyladenosine Methylation Modification in Fructose-Induced Non-Alcoholic Fatty Liver Disease.
Luo Y; Zhang Z; Xiang L; Zhou B; Wang X; Lin Y; Ding X; Liu F; Lu Y; Peng Y
Front Endocrinol (Lausanne); 2021; 12():780617. PubMed ID: 34950107
[TBL] [Abstract][Full Text] [Related]
2. METTL16-mediated translation of
Tang J; Zhao X; Wei W; Liu W; Fan H; Liu XP; Li Y; Wang L; Guo J
PeerJ; 2022; 10():e14379. PubMed ID: 36518278
[TBL] [Abstract][Full Text] [Related]
3. Abnormal m6A modification in non-alcoholic fatty liver disease.
Li Z; Qi J; Liu H; Tang Y; Liu J; Sun C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 46(8):785-792. PubMed ID: 34565720
[TBL] [Abstract][Full Text] [Related]
4. Ling-gui-zhu-gan decoction alleviates hepatic steatosis through SOCS2 modification by N6-methyladenosine.
Dang Y; Xu J; Yang Y; Li C; Zhang Q; Zhou W; Zhang L; Ji G
Biomed Pharmacother; 2020 Jul; 127():109976. PubMed ID: 32559839
[TBL] [Abstract][Full Text] [Related]
5. METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism.
Xie W; Ma LL; Xu YQ; Wang BH; Li SM
Biochem Biophys Res Commun; 2019 Oct; 518(1):120-126. PubMed ID: 31405565
[TBL] [Abstract][Full Text] [Related]
6. Polychlorinated biphenyls alter hepatic m6A mRNA methylation in a mouse model of environmental liver disease.
Petri BJ; Piell KM; Wahlang B; Head KZ; Andreeva K; Rouchka EC; Cave MC; Klinge CM
Environ Res; 2023 Jan; 216(Pt 3):114686. PubMed ID: 36341798
[TBL] [Abstract][Full Text] [Related]
7. New roles of N6-methyladenosine methylation system regulating the occurrence of non-alcoholic fatty liver disease with N6-methyladenosine-modified MYC.
Cheng W; Li M; Zhang L; Zhou C; Yu S; Peng X; Zhang W; Zhang W
Front Pharmacol; 2022; 13():973116. PubMed ID: 36120320
[TBL] [Abstract][Full Text] [Related]
8. Dynamic Patterns of N6-Methyladenosine Profiles of Messenger RNA Correlated with the Cardiomyocyte Regenerability during the Early Heart Development in Mice.
Yang Y; Shen S; Cai Y; Zeng K; Liu K; Li S; Zeng L; Chen L; Tang J; Hu Z; Xia Z; Zhang L
Oxid Med Cell Longev; 2021; 2021():5537804. PubMed ID: 34413927
[TBL] [Abstract][Full Text] [Related]
9. THE ROLE OF N6-METHYLADENOSINE METHYLTRANSFERASE RBM15 IN NONALCOHOLIC FATTY LIVER DISEASE.
Li S; Lian S; Cheng W; Zhang T; Gong X
Shock; 2024 Feb; 61(2):311-321. PubMed ID: 38150369
[TBL] [Abstract][Full Text] [Related]
10. N
Luo P; Li S; Jing W; Tu J; Long X
Trends Endocrinol Metab; 2023 Dec; 34(12):838-848. PubMed ID: 37758602
[TBL] [Abstract][Full Text] [Related]
11. Alteration of N6-methyladenosine epitranscriptome profile in lipopolysaccharide-induced mouse mesangial cells.
Liu T; Zhuang XX; Qin XJ; Wei LB; Gao JR
Naunyn Schmiedebergs Arch Pharmacol; 2022 Apr; 395(4):445-458. PubMed ID: 35119478
[TBL] [Abstract][Full Text] [Related]
12. Epitranscriptomics: Correlation of N6-methyladenosine RNA methylation and pathway dysregulation in the hippocampus of HIV transgenic rats.
Fu Y; Zorman B; Sumazin P; Sanna PP; Repunte-Canonigo V
PLoS One; 2019; 14(1):e0203566. PubMed ID: 30653517
[TBL] [Abstract][Full Text] [Related]
13. Persistent changes in liver methylation and microbiome composition following reversal of diet-induced non-alcoholic-fatty liver disease.
Kim H; Worsley O; Yang E; Purbojati RW; Liang AL; Tan W; Moses DID; Hartono S; Fan V; Lim TKH; Schuster SC; Foo RS; Chow PKH; Pettersson S
Cell Mol Life Sci; 2019 Nov; 76(21):4341-4354. PubMed ID: 31119300
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Analysis and Functional Characteristics of Differential Expression of N6-Methyladenosine Methylation Modification in the Whole Transcriptome of Rheumatoid Arthritis.
Wan L; Liu J; Huang C; Zhu Z; Wang K; Sun G; Zhu L; Hu Z
Mediators Inflamm; 2022; 2022():4766992. PubMed ID: 36330380
[TBL] [Abstract][Full Text] [Related]
15. Dysregulated m6A modification promotes lipogenesis and development of non-alcoholic fatty liver disease and hepatocellular carcinoma.
Yang Y; Cai J; Yang X; Wang K; Sun K; Yang Z; Zhang L; Yang L; Gu C; Huang X; Wang Z; Zhu X
Mol Ther; 2022 Jun; 30(6):2342-2353. PubMed ID: 35192934
[TBL] [Abstract][Full Text] [Related]
16. Changes in m6A in Steatotic Liver Disease.
Petri BJ; Cave MC; Klinge CM
Genes (Basel); 2023 Aug; 14(8):. PubMed ID: 37628704
[TBL] [Abstract][Full Text] [Related]
17. m6A RNA Methylation and Implications for Hepatic Lipid Metabolism.
Ming X; Chen S; Li H; Wang Y; Zhou L; Lv Y
DNA Cell Biol; 2024 Jun; 43(6):271-278. PubMed ID: 38635960
[TBL] [Abstract][Full Text] [Related]
18. Transcriptome-wide analysis of N6-methyladenosine uncovers its regulatory role in gene expression in the lepidopteran Bombyx mori.
Li B; Wang X; Li Z; Lu C; Zhang Q; Chang L; Li W; Cheng T; Xia Q; Zhao P
Insect Mol Biol; 2019 Oct; 28(5):703-715. PubMed ID: 30957943
[TBL] [Abstract][Full Text] [Related]
19. Whole-genome DNA methylation and gene expression profiling in the livers of mice with nonalcoholic steatohepatitis.
Bi H; Zhou B; Yang J; Lu Y; Mao F; Song Y
Life Sci; 2023 Sep; 329():121951. PubMed ID: 37473799
[TBL] [Abstract][Full Text] [Related]
20. RBM15 suppresses hepatic insulin sensitivity of offspring of gestational diabetes mellitus mice via m6A-mediated regulation of CLDN4.
Fang J; Wu X; He J; Zhang H; Chen X; Zhang H; Novakovic B; Qi H; Yu X
Mol Med; 2023 Feb; 29(1):23. PubMed ID: 36803098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
